Vicinium: Expiry of patents related to the use in the treatment of bladder and head and neck cancer in US, EU, Canada, China, Israel and Japan in April 2024 and June 2025

Vicineum (oportuzumab monatox) - CARISMA Therap

Mar 1, 2023